BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 19887444)

  • 21. Substrate-dependent dynamics of UDP-galactopyranose mutase: Implications for drug design.
    Boechi L; de Oliveira CA; Da Fonseca I; Kizjakina K; Sobrado P; Tanner JJ; McCammon JA
    Protein Sci; 2013 Nov; 22(11):1490-501. PubMed ID: 23934860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nucleophilic participation of reduced flavin coenzyme in mechanism of UDP-galactopyranose mutase.
    Sun HG; Ruszczycky MW; Chang WC; Thibodeaux CJ; Liu HW
    J Biol Chem; 2012 Feb; 287(7):4602-8. PubMed ID: 22187430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Probing UDP-galactopyranose mutase binding pocket: a dramatic effect on substitution of the 6-position of UDP-galactofuranose.
    Eppe G; Peltier P; Daniellou R; Nugier-Chauvin C; Ferrières V; Vincent SP
    Bioorg Med Chem Lett; 2009 Feb; 19(3):814-6. PubMed ID: 19119008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Eukaryotic UDP-galactopyranose mutase (GLF gene) in microbial and metazoal pathogens.
    Beverley SM; Owens KL; Showalter M; Griffith CL; Doering TL; Jones VC; McNeil MR
    Eukaryot Cell; 2005 Jun; 4(6):1147-54. PubMed ID: 15947206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification and partial characterization of two eukaryotic UDP-galactopyranose mutases.
    Bakker H; Kleczka B; Gerardy-Schahn R; Routier FH
    Biol Chem; 2005 Jul; 386(7):657-61. PubMed ID: 16207086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanistic investigation of UDP-galactopyranose mutase from Escherichia coli using 2- and 3-fluorinated UDP-galactofuranose as probes.
    Zhang Q; Liu H
    J Am Chem Soc; 2001 Jul; 123(28):6756-66. PubMed ID: 11448178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 1,4-Anhydrogalactopyranose is not an intermediate of the mutase catalyzed UDP-galactopyranose/furanose interconversion.
    Caravano A; Sinaÿ P; Vincent SP
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1123-5. PubMed ID: 16377186
    [TBL] [Abstract][Full Text] [Related]  

  • 28. UDP-4-Keto-6-Deoxyglucose, a Transient Antifungal Metabolite, Weakens the Fungal Cell Wall Partly by Inhibition of UDP-Galactopyranose Mutase.
    Ma L; Salas O; Bowler K; Bar-Peled M; Sharon A
    mBio; 2017 Nov; 8(6):. PubMed ID: 29162710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Steric Control of the Rate-Limiting Step of UDP-Galactopyranose Mutase.
    Pierdominici-Sottile G; Cossio-Pérez R; Da Fonseca I; Kizjakina K; Tanner JJ; Sobrado P
    Biochemistry; 2018 Jul; 57(26):3713-3721. PubMed ID: 29757624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and inhibition properties of conformational probes for the mutase-catalyzed UDP-galactopyranose/furanose interconversion.
    Caravano A; Mengin-Lecreulx D; Brondello JM; Vincent SP; Sinaÿ P
    Chemistry; 2003 Dec; 9(23):5888-98. PubMed ID: 14673861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A unique catalytic mechanism for UDP-galactopyranose mutase.
    Soltero-Higgin M; Carlson EE; Gruber TD; Kiessling LL
    Nat Struct Mol Biol; 2004 Jun; 11(6):539-43. PubMed ID: 15133501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemical probes of UDP-galactopyranose mutase.
    Carlson EE; May JF; Kiessling LL
    Chem Biol; 2006 Aug; 13(8):825-37. PubMed ID: 16931332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enzymatic synthesis of UDP-(3-deoxy-3-fluoro)-D-galactose and UDP-(2-deoxy-2-fluoro)-D-galactose and substrate activity with UDP-galactopyranose mutase.
    Barlow JN; Blanchard JS
    Carbohydr Res; 2000 Oct; 328(4):473-80. PubMed ID: 11093703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Crystal structures and small-angle x-ray scattering analysis of UDP-galactopyranose mutase from the pathogenic fungus Aspergillus fumigatus.
    Dhatwalia R; Singh H; Oppenheimer M; Karr DB; Nix JC; Sobrado P; Tanner JJ
    J Biol Chem; 2012 Mar; 287(12):9041-51. PubMed ID: 22294687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and analysis of substrate analogues for UDP-galactopyranose mutase: implication for an oxocarbenium ion intermediate in the catalytic mechanism.
    Itoh K; Huang Z; Liu HW
    Org Lett; 2007 Mar; 9(5):879-82. PubMed ID: 17266324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of recombinant UDP-galactopyranose mutase from Aspergillus fumigatus.
    Oppenheimer M; Poulin MB; Lowary TL; Helm RF; Sobrado P
    Arch Biochem Biophys; 2010 Oct; 502(1):31-8. PubMed ID: 20615386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitors of UDP-galactopyranose mutase thwart mycobacterial growth.
    Dykhuizen EC; May JF; Tongpenyai A; Kiessling LL
    J Am Chem Soc; 2008 May; 130(21):6706-7. PubMed ID: 18447352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of Novel Inhibitors of UDP-Galactopyranose Mutase by Structure-Based Virtual Screening.
    Karunan Partha S; Sadeghi-Khomami A; Cren S; Robinson RI; Woodward S; Slowski K; Berast L; Zheng B; Thomas NR; Sanders DA
    Mol Inform; 2011 Oct; 30(10):873-83. PubMed ID: 27468107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of novel inhibitors against UDP-galactopyranose mutase to combat leishmaniasis.
    Kashif M; Tabrez S; Husein A; Arish M; Kalaiarasan P; Manna PP; Subbarao N; Akhter Y; Rub A
    J Cell Biochem; 2018 Mar; 119(3):2653-2665. PubMed ID: 29058760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemistry and biology of galactofuranose-containing polysaccharides.
    Richards MR; Lowary TL
    Chembiochem; 2009 Aug; 10(12):1920-38. PubMed ID: 19591187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.